- Insulet announced full U.S. market release of Omnipod Discover.
- Platform is web-based, designed for Omnipod 5 users, caregivers, and HCPs.
- Over 15,000 users and 1,800 HCPs adopted it during limited release.
- Real-world data showed 32% of users had clinically meaningful TIR increase of 3% or more.
- Platform is available in Spain, Australia, Saudi Arabia, Qatar, Kuwait, UAE, and Israel.
- Insulet announced the full U.S. market release of Omnipod Discover, a web-based data platform for Omnipod 5 users, caregivers, and healthcare providers. The platform converts diabetes data into visualizations and personalized insights. It was already adopted by over 15,000 users and 1,800 HCPs during a limited release. Real-world data presented at the ADA Scientific Sessions showed 32% of users achieved a clinically meaningful increase in time in range of 3% or more.
The headline and the read are open. The reasons are one free account away, on every story.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.
BORSAPLUSWhy it matters · Bull and bear case · Reaction against SPY and the sector · What to watch
Create a free account · no card